Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infertility in Males01:23

Infertility in Males

712
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
712
Menopause01:28

Menopause

5.2K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.2K
Infertility in Females01:28

Infertility in Females

5.1K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
5.1K
Oogenesis02:07

Oogenesis

71.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.7K
Spermatogenesis01:41

Spermatogenesis

125.1K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
125.1K
Bone Disorders01:29

Bone Disorders

8.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Gestational Age Measurement Technique on the Associations Between Maternal Characteristics and Birth Outcomes.

Paediatric and perinatal epidemiology·2026
Same author

Leveraging Menstrual Effluent to Investigate Vitamin D and Human Decidualization: A Potential Link with Fertility.

The Journal of clinical endocrinology and metabolism·2026
Same author

The Investigation of Vitamin D and Menstrual Cycles Trial (the inVitD Trial): A clinical trial of vitamin D supplementation on the hypothalamic-pituitary-ovarian axis.

Contemporary clinical trials·2025
Same author

Pregnancy Length Measurement Error: A Comparison of Last Menstrual Period and Ultrasonography with Ovulation-based Estimation.

Epidemiology (Cambridge, Mass.)·2025
Same author

Ambient air pollution in critical windows of exposure and spontaneous miscarriage in a preconception cohort.

Environmental research·2025
Same author

Inflammation and Ovarian Function in Reproductive-Aged Women.

American journal of human biology : the official journal of the Human Biology Council·2024

Related Experiment Video

Updated: Apr 17, 2026

Human Egg Maturity Assessment and Its Clinical Application
08:51

Human Egg Maturity Assessment and Its Clinical Application

Published on: August 19, 2019

20.5K

Age-related infertility.

Natalie M Crawford1, Anne Z Steiner1

  • 1Reproductive Endocrinology and Infertility, University of North Carolina, 4001 Old Clinic Building, CB 7570, Chapel Hill, NC 27599, USA.

Obstetrics and Gynecology Clinics of North America
|February 16, 2015
PubMed
Summary
This summary is machine-generated.

Female fertility declines significantly with age, particularly after 35. Prompt infertility evaluation and tailored treatments, including oocyte donation, are crucial for older women seeking pregnancy.

Keywords:
Advanced maternal ageAgingDonor oocytesInfertilityOvarian reserve

More Related Videos

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
09:50

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture

Published on: October 24, 2025

907
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 17, 2026

Human Egg Maturity Assessment and Its Clinical Application
08:51

Human Egg Maturity Assessment and Its Clinical Application

Published on: August 19, 2019

20.5K
Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
09:50

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture

Published on: October 24, 2025

907
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.7K

Area of Science:

  • Reproductive Endocrinology
  • Geriatric Gynecology
  • Infertility Medicine

Background:

  • Oocyte quantity and quality diminish with increasing maternal age.
  • Female fecundity experiences a marked decline after the mid-thirties.

Purpose of the Study:

  • To outline the impact of advanced maternal age on fertility.
  • To recommend timely infertility evaluations and treatment strategies for older women.

Main Methods:

  • Review of age-related changes in oocyte reserve and quality.
  • Analysis of recommended timelines for infertility assessment in women over 35.
  • Evaluation of treatment options, including ovarian reserve testing and oocyte donation.

Main Results:

  • A rapid decline in fertility occurs after age 35.
  • Abnormal ovarian reserve tests indicate a poorer prognosis and necessitate aggressive treatment.
  • Oocyte donation offers the most effective solution for age-related infertility.

Conclusions:

  • Women over 35 should undergo infertility evaluation within 6 months.
  • Prompt assessment and personalized treatment plans are vital for improving pregnancy outcomes in older women.
  • Counseling and evaluation are essential before initiating infertility treatments for advanced-age patients.